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OBJECTIVE: Poor sleep quality is one of the factors that adversely affects patient quality of life after kidney
transplantation, and sleep disorders represent a significant cardiovascular risk factor. The objective of this study was
to investigate the prevalence of changes in sleep quality and their outcomes in kidney transplant recipients and
analyze the variables affecting sleep quality in the first years after renal transplantation.
METHODS: Kidney transplant recipients were evaluated at two time points after a successful transplantation:
between three and six months (Phase 1) and between 12 and 15 months (Phase 2). The following tools were used for
assessment: the Pittsburgh Sleep Quality Index; the quality of life questionnaire Short-Form-36; the Hospital Anxiety
and Depression scale; the Karnofsky scale; and assessments of social and demographic data. The prevalence of poor
sleep was 36.7% in Phase 1 and 38.3% in Phase 2 of the study.
RESULTS: There were no significant differences between patients with and without changes in sleep quality
between the two phases. We found no changes in sleep patterns throughout the study. Both the physical and
mental health scores worsened from Phase 1 to Phase 2.
CONCLUSION: Sleep quality in kidney transplant recipients did not change during the first year after a successful
renal transplantation.
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INTRODUCTION
Sleep disorders are more common in patients with chronic
kidney disease (CKD) undergoing dialysis (1,2) than in the
general population (3). Successful renal transplantation is
expected to correct most abnormalities of CKD and sig-
nificantly improve the patients’ health-related quality of life
(HRQoL) (4-7), but some studies have demonstrated that
sleep disorders do not always improve after transplantation
(6-9).
The sleep quality and quality of life of kidney transplant
recipients are known to be affected by several factors, such
as social-demographic variables, comorbidities, psychiatric
disorders, and other physical conditions, including tobacco
use, uremia, malnutrition, and anemia (10). Sleep-related
disorders have become a focus of interest for research due to
increasing evidence of an association between cardiovascu-
lar disturbances and sleep apnea-hypopnea syndrome
(11,12). In addition, studies have suggested that sleep
disorders are closely linked to physical, psychological and
social well-being (13) and cognitive function (14,15).
Detecting the presence of sleep disorders after successful
renal transplantation and obtaining a better understanding
of this outcome is thus very important due to its impact on
patient HRQoL, the perception of changes in lifestyle and
well-being and the adherence to treatment.
Therefore, the present study was conducted to prospec-
tively assess sleep quality and HRQoL in kidney transplant
recipients at two time points after a successful transplanta-
tion. We examined patients during the initial phase (3-6
months post-transplant) and at the second year post-
procedure to determine whether there had been changes
in sleep quality over time after transplantation. This is a
relevant issue because sleep disorders are highly prevalent
in patients with chronic kidney disease and are associated
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with increased cardiovascular risk in addition to having a
negative impact on the quality of life of this population.
PATIENTS AND METHODS
Patients who received kidney transplants at the Renal
Transplantation Service of Hospital das Clı´nicas of
University of Sa˜o Paulo School of Medicine (HC/FMUSP)
from January 1st to December 31st, 2008, were selected to
participate in this study.
Eligible patients were individuals 18 years of age or older
who had undergone renal transplantation in the past three to
six months, had stable renal function with creatinine clearance
above 40 mL/min, and who agreed to participate in the study
by signing the informed consent form. Patients who were
hospitalized within 30 days of inclusion, night-shift workers,
patients with active infection, patients who were previously
diagnosed with depression, and patients who declined to
participate in any phase of the study were excluded.
At inclusion, information was collected about patient age,
gender, race, educational background (years of schooling),
marital and employment status and medical history.
Information on the presence of comorbidities, type of donor,
time on dialysis, and laboratory data was retrieved from the
patients’ hospital files.
All patients were interviewed on two occasions: between
the third and the sixth month after transplantation and
between the 12th and the 15th month after transplantation.
On both occasions, the following variables were assessed:
sleep quality using the Pittsburg Sleep Quality Index (PSQI);
quality of life perception using the Short-Form Health
Survey (SF-36); the presence of anxiety or depression using
the Hospital Anxiety and Depression (HAD) scale; and
patient self-care ability using the Karnofsky scale.
Quality of sleep
The PSQI is a self-administered questionnaire that
evaluates sleep quality over the past month. It contains 19
questions regarding subjective sleep quality, latency, dura-
tion, efficacy, disorders, use of sleep medications, and daily
sleep problems. Each component is assessed on a 0 to 3
scale, generating a global score between 0 and 21; higher
scores indicate lower sleep quality.
The PSQI identifies two groups of patients: poor sleepers
(PSQI.5) and good sleepers (PSQI,5). A global score .5
indicates that the person is a poor sleeper and has severe
difficulties in at least two areas or moderate difficulties in
more than three areas (16-18). In this study, patients with a
score equal to or below 5 were considered as having normal
sleep patterns.
Health-related quality of life (HRQoL)
Quality of life was evaluated using the Short-Form Health
Survey (SF-36), which consists of eight sub-scales: physical
function, role limitation attributable to physical problems,
bodily pain, perception of general health, social function,
vitality, role limitation attributable to emotional problems,
and mental health. The sub-scales are presented as scores
between 0 and 100, with higher scores indicating a better
health status (19).
Hospital anxiety and depression (HAD)
The HAD scale consists of 14 items, of which seven
evaluate anxiety (HAD-A) and seven evaluate depression
(HAD-D). Each item may be scored from 0 to 3, generating a
maximum total score of 21 for each scale. Scores equal to or
higher than 9 indicate the presence of symptoms of
depression or anxiety (20).
Karnofsky scale
The Karnofsky scores were used to assess physical health
status as follows: 100–normal; 90-minor signs or symptoms
of disease; 80-normal activity with effort; 70–unable to carry
out normal activity; 60-requires occasional assistance; 50–
requires considerable assistance; 40-disabled; 30-severely
disabled; 20-hospital admission necessary; 10-moribund.
Patients were considered as ‘‘rehabilitated’’ when the
Karnofsky score was 70 to 100, ‘‘able to care for personal
needs’’ when the score was 60, ‘‘requiring considerable
assistance’’ when the score was 30 to 50, and ‘‘requiring
hospital admission’’ when the score was 10 to 20 (21).
Statistics
The Kolmogorov-Smirnov test was used to verify data
normality. Student’s t test was used to compare group
averages. Whenever the data normality assumption was
rejected, the non-parametric Mann-Whitney test was used.
To compare group behavior at each timepoint, we used the
paired t test for normally distributed data and the non-
parametric Wilcoxon test for non-normally distributed data.
The non-parametric McNemar test was used to compare the
classification data between Phase 1 and Phase 2.
Ethics
This study was approved by the local Research Ethics
Committee. Before inclusion, patients received detailed
verbal and written information about the study objectives
and procedures and signed the informed consent form.
RESULTS
In 2008, 163 renal transplantation procedures were
performed at the HCFMUSP, 156 of which were successful.
Seventy-six patients met the study inclusion criteria and
were included. The details of the inclusion process are
shown on Figure 1.
The study population was 60% white, with a mean age of
42¡12 years and similar proportions of male and female
subjects. Recipients of transplants from living donors
represented 59% of the population; the most frequently
used immunosuppressive regimen was the triple combina-
tion of tacrolimus, mycophenolate mofetil, and prednisone.
Table 1 shows a detailed profile of the study sample.
Renal function and hematological parameters remained
stable throughout the study period, but a significant
increase in body mass index (BMI) was observed between
the two assessments (Table 2).
There was a significant increase in the proportion of
patients who were able to work, from 13 (21.7%) in Phase 1
to 28 (46.7%) in Phase 2 (p = 0.006).
Sleep quality and health-related quality of life
outcomes after renal transplantation
We observed poor sleep quality in 22 (36.7%) and 23
(38.3%) patients in Phases 1 and 2 of the study, respectively.
The mean PSQI showed no significant change from Phase 1
to Phase 2 (5.4 vs. 5.8; p= 0.319).
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Most SF-36 domains also failed to show significant
differences between Phase 1 and 2. However, the vitality
(p= 0.015) and role emotional (p = 0.015) domains showed
significant differences at follow-up (Figure 2).
The presence of anxiety and/or depression symptoms
and self-care ability, as measured on the Karnofsky scale,
were not significantly different at the two time points, as
shown in Table 2.
When questioned about their perceived health improve-
ments from the previous year, 93.3% and 85% of the patients
reported improvements in Phase 1 and Phase 2 of the study,
respectively.
Influence of sleep quality on health-related quality
of life and self-care ability after renal
transplantation
When we categorized the patients as poor sleepers
(PSQI.5) or good sleepers (PSQI,5) according to the
PSQI, we found no significant difference between these
groups with respect to demographics, clinical and labora-
tory data, or renal transplantation parameters (Table 3).
However, we found that the body mass index was higher in
the poor sleepers group, in which 17.4% of the patients
required sleep medication (Table 3).
Figure 1 - Study enrollment flowchart.
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The poor sleepers group showed worse role physical
(p = 0.034), social functioning (p= 0.040), and Karnofsky
index (p = 0.031) scores, even in the early post-transplanta-
tion period. A more frequent use of benzodiazepines and
anti-anxiety medication and higher BMI values were
observed in the poor sleepers group (Table 4). We also
found an inverse correlation between BMI and Karnofsky
score; among poor sleepers, patients with higher body mass
index values had lower Karnofsky index values. During
Phase 1 of the study, labor activity was a significant driver
of good sleep quality (p= 0.018). The use of benzodiazepines
or anti-anxiety medication was associated with worse SQ in
both phases (p,0.001). We found no correlation between
napping or smoking and SQ.
DISCUSSION
There have been a number of cross-sectional studies on
sleep quality and sleep disorders (2,6,7,9,10,23-29), but none
have assessed sleep quality longitudinally after transplanta-
tion. To the best of our knowledge, this study is the first to
conduct a sequential assessment of sleep quality in kidney
transplant recipients, including the late post-transplantation
phase.
Our findings showed no significant change in sleep
quality from the early postoperative period to one year
after transplantation. We found a high prevalence of poor
sleepers [PSQI.5] at the first time point, and the prevalence
remained unchanged in the second assessment. We found
no difference in the mean PSQI between the two assess-
ments.
This study only included patients with adequate graft
function and excluded patients with a current diagnosis of
depression or recent hospitalization because those factors
might have had a negative influence on patient sleep quality
and quality of life and thus increase the heterogeneity of the
sample. Therefore, we conclude that despite a successful
transplantation, sleep quality did not improve over the
study period.
We found no time-dependent change in most quality of
life parameters between the two assessments. However,
there was a significant difference in the vitality and role
emotional scores, suggesting a worsening of these domains
over time. Previous cross-sectional studies on sleep quality
and quality of life found low scores for these domains in
transplant recipients compared with other CKD patients
and controls (9,10,22,24). When we compared good sleepers
(PSQI,5) and poor sleepers (PSQI.5), we found that the
poor sleepers had lower scores in the SF-36 domains,
particularly the role physical and social function domains.
We found that 10% of patients exhibited depressive
symptoms in each phase, while anxiety symptoms were
observed in 10% of patients in Phase 1 and 15% of patients
in Phase 2. These values are lower than those found in other
studies, i.e., 22 to 39% (32) for depressive symptoms and 10
to 22% for clinical depression (31). This difference may be
explained by our exclusion of patients with clinical
depression at baseline and/or by our use of a symptom
screening tool (HAD). Our study was not designed to
diagnose anxiety or depression, but because we used a
screening tool, it could be expected that these symptoms
would be reported by some patients. The association of
anxiety and depression symptoms with poor sleep quality
in kidney transplant recipients has been reported previously
(30-33), but our study failed to show such an association.
Some reports consider biological and clinical factors to be
significant predictors of the SF-36 physical component
score, even though these factors can only explain part of
the observed changes (5,33,34). However, no correlation has
been identified between these variables and the mental
health component of the SF-36. Based on these findings,
researchers have suggested that comparisons should con-
sider patient age because this variable affects perceived
quality of life. To date, no studies have assessed additional
personal, environmental and/or clinical factors that might
influence the patient perception of quality of life after renal
transplantation.
In our study, we also analyzed the correlation between
BMI and sleep quality. Sleep disorders, such as sleep apnea,
Table 1 - Patient characteristics.
Male – n (%) 31 (51.7)
Age (years) (mean/SD) 42/12
White 36 (60.0)
Years of education - n (%)
,8 32 (52.4)
8-12 20 (33.3)
Undergraduate/graduate degree 8 (13.3)
Non-smoking – n (%) 57 (95.0)
Marital status – n (%)
Single/widowed/divorced 27 (45.0)
Married 33 (55.0)
Immunosuppressive regimen – n (%)
Tacrolimus 57 (95.0)
Prednisone 60 (100.0)
Mycophenolate mofetil 49 (81.7)
Comorbidity- n (%)
Hypertension 33 (55.0)
Diabetes mellitus 11 (18.3)
Donor – n (%)
Living 35 (58.3)
Deceased 25 (41.7)
Table 2 - Clinical and laboratory data, sleep quality and
HRQoL in each study phase.
Phase 1 Phase 2
3-6m Tx 12-15m Tx
MeaniSD MeaniSD p
n = 60 n = 60
Serum
creatinine(mg/dl)
1.3¡0.3 1.3¡0.4 0.783*
Hematocrit 42.0¡6.8 41.7¡4.9 0.546*
Hemoglobin (g/L) 13.5¡2.3 13.5¡1.7 0.929*
BMI 25.5¡5.3 26.4¡5.8 , 0.001*
Physical functioning 88¡11.6 87¡16.6 0.723**
Role physical 73.3¡33.4 79.5¡12.6 0.172**
Bodily pain 74.1¡16.5 71.3¡23.9 0.422**
General health 47.8¡17.6 46.3¡16.8 0.363**
Vitality 76¡16.7 70.9¡19.3 0015**
Social functioning 76¡28.1 68.2¡32.3 0.156**
Role emotional 67.2¡36.5 54.4¡37.3 0.015**
Mental health 72.8¡20.6 71.2¡18 0.610**
Depression (HAD) 3.1¡3.4 3.6¡3.6 0.432**
Anxiety (HAD) 4.9¡3.2 5.8¡3.7 0.113**
Karnofsky 92.5¡8.9 93.5¡8.2 0.326**
PSQI 5.4¡4.0 5.8¡3.9 0.319**
(*) paired t test; (**) Wilcoxon non-parametric testBMI, body mass index;
HAD, hospital anxiety and depression; PSQI, Pittsburgh sleep quality
index; SF36 –domains.
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are expected to be associated with high BMI and neck
circumference (12). Although our study was designed to
assess sleep quality in general and not sleep disorders, we
found a correlation between body mass index and sleep
deprivation.
Perceived self-care ability was measured on the
Karnofsky scale, and we found a negative correlation
between poor sleep quality and Karnofsky score. Previous
studies support these findings, showing improvements in
the Karnofsky and Disease Impact scores after transplanta-
tion (35,36). We could therefore assume that the degree of
independence, as measured by the patient’s self-care ability,
may be important for sleep quality.
In our study, patients who were employed reported
significantly better sleep quality early after transplantation
compared to the patients who did not work. This result
suggests that working may be important to achieving good
sleep quality, although it should be noted that only a few
patients were actively working at that time. Some authors
believe that occupation and social reintegration are directly
linked to good sleep quality and quality of life (4,5,33,37).
Their studies support our findings that having an occupa-
tion may be associated with good sleep quality in kidney
transplant recipients.
Due to the logistic limitations of including recipients of
deceased donor transplants, our study did not assess
patients prior to transplantation; therefore, we cannot
compare the pre-transplantation period with the other two
time points.
Figure 2 - Comparison of SF-36 domain and PSQI scores in Phase 1 vs. Phase 2.
Table 3 - Clinical and social characteristics versus sleep
quality.
PSQI p
# 5 (n= 37) . 5(n= 23)
Age (years) Mean ¡ SD 40.08¡11.86 46.00¡11.66 0.064(1)
Gender Female 16 (43.2%) 13 (56.5%) 0.317(2)
Male 21 (56.8%) 10 (43.5%)
Ethnicity Caucasian 15 (40.5%) 9 (39.1%) 0.914(2)
Other 22 (59.5%) 14 (60.9%)
Lives with Yes 21 (56.8%) 12 (52.2%) 0.729(2)
partner No 16 (43.2%) 11 (42.8%)
Employment
status
11 (29.7%) 2 (8.7%) 0.105(3)
Smoker 1 (2.7%) 2 (8.7%) 0.552(3)
Medication 0 (0.0%) 4 (17.4%) 0.018(3)
Diurnal
somnolence
18 (48.7%) 15 (65.2%) 0.210(2)
Donor Living 24 (65%) 11 (45.%)
Deceased 13 (35.1%) 12 (52.1%) 0.462(3)
Serum
creatinine
(mg/dL)
1.32¡0.37 1.41¡0.36 0.322(1)
Hemoglobin
(g/L)
13.5¡2.8 13.5¡1.4 0.899(1)
Hematocrit 42.1¡8.1 41.8¡4.1 0.856(1)
BMI 24.42¡4.66 27.30¡5.98 0.041(1)
Diabetes 5 (13.5%) 6 (26.1%) 0.306(3)
Hypertension 18 (48.7%) 15 (65.2%) 0.210(2)
Dialysis
(months)
27.38¡27.85 38.91¡39.23 0.220(4)
(1) Student’s t test; (2) chi-square test; (3) Fisher’s exact test; (4) Mann-
Whitney non-parametric test. Data are presented as mean¡SD or n (%) as
appropriate.
Table 4 - Relationship between HRQoL and sleep quality
after renal transplantation.
PSQI , 5 PSQI . 5 p*
Physical
functioning
90.1¡10.6 84.7¡12.7 0.053
Bodily pain 76.2¡16.3 70.7¡16.6 0.147
Vitality 77.5¡16.4 73.4¡17.4 0.350
Role emotional 71.1¡37.8 60.8¡34.3 0.173
Role physical 80.4¡30.1 61.9¡36.0 0.034
General health 45.6¡17.5 51.4¡17.5 0.476
Social
functioning
82.0¡24.5 66.3¡31.1 0.040
Mental health 74.9¡19.2 69.3¡22.7 0.340
Depression (HAD) 2.8¡3.1 3.4¡3.6 0.513
Anxiety (HAD) 4.7¡3.1 5.1¡3.3 0.591
Karnofsky 94.3¡8.6 89.5¡8.7 0.031
*Mann-Whitney non-parametric test.Data are presents as Mean¡SD.
Hospital Anxiety Depression.
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One relevant contribution of our study was to show that
the prevalence of poor sleep quality remains high after
successful renal transplantation and that clinicians should
pay attention to subjective factors associated with sleep
quality and quality of life even after the first year post-
transplantation. The assessment of sleep quality in routine
post-transplantation follow-up might contribute signifi-
cantly to the identification and treatment of these disorders.
Additionally, social reintegration and a return to profes-
sional activities seem to contribute to improved sleep
quality in the first year after renal transplantation.
Determining the influence of the transplantation team on
late post-procedural psychological, emotional, and social
aspects may help to improve adherence to therapy and
patient perception of sleep quality and quality of life.
Further studies should address possible interventions, such
as identifying patients at risk of emotional and psychosocial
conflicts, that might influence treatment outcomes and sleep
quality while maintaining the focus on the multidisciplinary
approach of renal transplantation.
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